Form of Proxy

RECURSION PHARMACEUTICALS, INC.

Notes

BD Client Code:

Client Name:

Number of Shares Held in a BD Nominee Company:

No.	Proposition		For	Against	Abstain
1	DIRECTOR Najat Khan, Ph.D.
2	DIRECTOR Franziska Michor, Ph.D.
3	Advisory vote to approve executive compensation as disclosed in the 2026 Proxy Statement.
4	Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year ending December 31, 2026.